Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Syndax Pharmaceuticals (SNDX) over the last 2 years, with Q3 2025 value amounting to $5.9 million.

  • Syndax Pharmaceuticals' Change in Receivables rose 19792.59% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year increase of 52435.13%. This contributed to the annual value of $7.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Syndax Pharmaceuticals' Change in Receivables is $5.9 million, which was up 19792.59% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Syndax Pharmaceuticals' Change in Receivables ranged from a high of $8.1 million in Q1 2025 and a low of -$6.1 million during Q3 2024